The Journal of Reproductive Medicine
Patients who may not be appropriate candidates include: Individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Those with a history of severe hypersensitivity reactions to semaglutide Patients with a history of pancreatitis (relative contraindication requiring careful risk-benefit assessment) Pregnant women or those planning pregnancy (contraindicated for weight management
Ages 3045: 0.150.25 mg nightly Ages 4660: 0.20.3 mg nightly Ages 61 and older: 0.10.2 mg nightly Weight modifiers: Under 150 lb: reduce dose by 0.05 mg Over 200 lb: increase dose by 0.05 mg Tailoring the Sermorelin Dosage Chart to Your Goals For anti-aging benefits (skin elasticity, sleep quality), aim for lower IGF-1 targets
FDA-designated for lipodystrophy research Visceral tissue targeting in published studies Lean tissue preservation research Cognitive pathway research applications MOTS-c A mitochondrial-derived peptide with documented metabolic pathway interactions
Obesity treatment should be personalizednot reduced to a simple choice between a pill and an injection
TB-500 is one option that may be added after a careful review of your history, symptoms, and goals
